Boston Scientific Logo

Coaptite® Injectable Implant

Coaptite Injectable Implant, a next generation bulking agent for female patients, is designed to offer improved procedural ease of use, fewer reinjections, and less material volume versus other approved bulking agents while maintaining the durability characteristics of a synthetic product.
 Contact Us About This Product

Product Information

Ease of Use:
  • 21 gauge needle is designed to reduce product extravation
  • No refrigeration storage is required to the Coaptite implant
  • No skin test required

Material Volume:

  • Reduces the amount of implant in the patient
  • Fewer syringe exchanges potentially reduce the risk of needle movement during injections
  • Potentially reduces cost to facility and patient
  • May reduce procedure time


  • Tissue infiltration potentially restores natural tissue in the body
  • 63.4% of Coaptite Implant patients maintained a 1 or more Stamey grade improvement at one year*

*FDA PMA Clinical Trial. Document on file.

Device Illustration

Coaptite® Injectable Agent Schematic

Device Highlights

  1. 1ml syringe
  2. Sidekick® Needle 14.6 inch, 21g

Reimbursement (Physician & Facility)

  • Click here to view current Urethral Bulking with Coaptite Injectable Implant Coding and Reimbursement Guide.
  • Click here to view all Gynecology coding and reimbursement content.

Additional Information

Federal (USA) law and governing law outside the USA restrict these devices to sale by or on the order of a physician trained in diagnostic and therapeutic cystoscopy.

Refer to insert provided with product for complete Instructions for Use, Indications for Use, Contraindications, Potential Adverse Effects, Warnings and Cautions.

Coaptite is a trademark of Merz Aesthetics, Inc.

Image Gallery
Coaptite Implant procedure step 2 Coaptite Implant procedure step 3 Coaptite Implant procedure step 4 Coaptite Implant procedure step 5

Product Type

Bulking Agent
TRUSTe European Safe Harbor certification